Needham & Company LLC reiterated their buy rating on shares of OrthoPediatrics (NASDAQ:KIDS – Free Report) in a research note issued to investors on Friday, Benzinga reports. The firm currently has a $42.00 price target on the stock.
Several other research firms have also recently weighed in on KIDS. Truist Financial reissued a hold rating and issued a $30.00 price target (down previously from $35.00) on shares of OrthoPediatrics in a research note on Thursday, August 8th. JMP Securities reiterated a market outperform rating and issued a $50.00 price objective on shares of OrthoPediatrics in a research report on Tuesday, May 7th.
Get Our Latest Stock Analysis on OrthoPediatrics
OrthoPediatrics Stock Down 1.0 %
Institutional Investors Weigh In On OrthoPediatrics
A number of institutional investors have recently made changes to their positions in KIDS. Deerfield Management Company L.P. Series C purchased a new position in shares of OrthoPediatrics during the 2nd quarter worth approximately $203,000. AQR Capital Management LLC acquired a new position in OrthoPediatrics during the second quarter worth $223,000. Paradigm Capital Management Inc. NY boosted its position in shares of OrthoPediatrics by 8.0% during the second quarter. Paradigm Capital Management Inc. NY now owns 134,400 shares of the company’s stock worth $3,865,000 after buying an additional 10,000 shares during the period. Sei Investments Co. grew its stake in shares of OrthoPediatrics by 345.2% in the second quarter. Sei Investments Co. now owns 30,747 shares of the company’s stock valued at $884,000 after buying an additional 23,841 shares in the last quarter. Finally, Divisadero Street Capital Management LP acquired a new stake in shares of OrthoPediatrics in the second quarter valued at $514,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.
About OrthoPediatrics
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
See Also
- Five stocks we like better than OrthoPediatrics
- What Are Dividend Challengers?
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- The Most Important Warren Buffett Stock for Investors: His Own
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.